Cargando…

High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy

The plasticity of AML drives poor clinical outcomes and confounds its longitudinal detection. However, the immediate impact of treatment on the leukemic and non-leukemic cells of the bone marrow and blood remains relatively understudied. Here, we conducted a pilot study of high dimensional longitudi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrell, Paul Brent, Diggins, Kirsten Elizabeth, Polikowsky, Hannah Grace, Mohan, Sanjay Ram, Seegmiller, Adam C., Irish, Jonathan Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830605/ https://www.ncbi.nlm.nih.gov/pubmed/27074138 http://dx.doi.org/10.1371/journal.pone.0153207

Ejemplares similares

Machine learning reveals chronic graft-versus-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies
por: Gandelman, Jocelyn S., et al.
Publicado: (2019)

Demethylator phenotypes in acute myeloid leukemia
por: Kelly, Andrew D., et al.
Publicado: (2018)

Induction of Differentiation of Mouse Myeloid Leukemia M1 Cells by Serum of Patients with Chronic Myeloid Leukemia
por: Okabe‐Kado, Junko, et al.
Publicado: (1988)

Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia‐type intensive induction therapy and stem cell transplantation
por: Chan, Onyee, et al.
Publicado: (2017)

Papular eruption after induction chemotherapy for acute myeloid leukemia
por: Novice, Taylor, et al.
Publicado: (2020)

Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?
por: Jaramillo, Sonia, et al.
Publicado: (2021)

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry
por: Yoo, Kwai Han, et al.
Publicado: (2021)

In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment
por: Shah, Amy T., et al.
Publicado: (2015)

Novel Translocation in Acute Myeloid Leukemia: Case Report and Review of Risk-Stratification and Induction Chemotherapy in Patients With Acute Myeloid Leukemia
por: Jeha, George M., et al.
Publicado: (2020)

Mixed-phenotypic acute leukemia: cytochemically myeloid and phenotypically early T-cell precursor acute lymphoblastic leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2014)

Fatal Idiopathic Hyperammonemia after Induction Chemotherapy for Acute Myeloid Leukemia
por: Angelo, Christophe, et al.
Publicado: (2020)

Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?
por: McCurdy, Shannon R., et al.
Publicado: (2021)

Neutropenic Enterocolitis Complicating Induction Chemotherapy in an Acute Myeloid Leukemia Patient
por: Groudan, Kevin, et al.
Publicado: (2021)

Treatment of Acute Myeloid Leukemia in the Era of Genomics—Achievements and Persisting Challenges
por: Green, Steven D., et al.
Publicado: (2020)

Bilateral proptosis and bitemporal swelling: A rare manifestation of acute myeloid leukemia
por: Rajput, Dinesh, et al.
Publicado: (2010)

Acute Myeloid Leukemia Stem Cells: The Challenges of Phenotypic Heterogeneity
por: Arnone, Marlon, et al.
Publicado: (2020)

Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia
por: Cesano, Alessandra, et al.
Publicado: (2015)

FoxO1-Dependent Induction of Acute Myeloid Leukemia by Osteoblasts in Mice
por: Kode, Aruna, et al.
Publicado: (2015)

Low-intensity induction in acute myeloid leukemia. Always in the patients' best interest?
por: Atallah, Ehab
Publicado: (2022)

Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia
por: Zhang, Baohang, et al.
Publicado: (2023)

Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
por: Ofran, Yishai
Publicado: (2023)

Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapy
por: Ihlow, Jana, et al.
Publicado: (2021)

Epidemiology of de novo Acute Myeloid Leukemia in Kuwait per the 2016 WHO Classification
por: Alshemmari, Salem H., et al.
Publicado: (2022)

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia
por: Tiong, Ing S., et al.
Publicado: (2021)

Concurrent Onset of Chronic Lymphocytic Leukemia and Atypical Phenotype Acute Myeloid Leukemia Revealed by Autopsy
por: Kiso, Sayaka, et al.
Publicado: (2021)

Eryptotic Phenotype in Chronic Myeloid Leukemia: Contribution of Neutrophilic Cathepsin G
por: Govekar, Rukmini, et al.
Publicado: (2012)

ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia
por: Tota, Giuseppina, et al.
Publicado: (2014)

Human Leukocyte Antigen-B27: The Genetic Predisposition Leading to Reactive Arthritis during Induction Phase Chemotherapy for Acute Myeloid Leukemia
por: Bartakke, Sandip P, et al.
Publicado: (2017)

Acute myeloid leukemia with myelodysplasia-related changes and blasts of the mixed T/myeloid phenotype: a case report
por: Sheng, Xian-Fu, et al.
Publicado: (2022)

Inhibitory Action of Transforming Growth Factor‐β on Induction of Differentiation of Myeloid Leukemia Cells
por: Okabe‐Kado, Junko, et al.
Publicado: (1989)

Acute Myeloid Leukemia with Occult Systemic Mastocytosis or Atypical Mast Cells Post-induction
por: Khan, Salahuddin, et al.
Publicado: (2018)

Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia
por: Vey, Norbert
Publicado: (2020)

Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual case.
por: Tavarozzi, Rita, et al.
Publicado: (2021)

Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022)

Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia
por: Wei, Hui, et al.
Publicado: (2020)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
por: Cherry, Evan M., et al.
Publicado: (2021)

Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia
por: Liu, Qingguo, et al.
Publicado: (2020)

P546: MACHINE LEARNING AND RESPONSE TO INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Elhaddad, Heba, et al.
Publicado: (2023)

Daratumumab‐based induction and autologous transplantation in concomitant multiple myeloma and chronic myeloid leukemia
por: Liberatore, Carmine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fe3ie4fm0s41d5vgqg7nirm9vk